Parameter | Controls | Patients without MHE (p vs. control) | Patients with MHE (p vs. control) | p values (without MHE vs. with MHE) | Global ANOVA |
---|---|---|---|---|---|
p values | |||||
PHES | −0.2 ± 0.8a | −0.4 ± 0.8 | −6 ± 2 | <0.001 | <0.0001 |
p < 0.001 | |||||
Nitrates + Nitrites (μM) | 18 ± 3 | 24 ± 8 | 29 ± 8 | ns | <0.0001 |
p < 0.05 | p < 0.001 | ||||
cGMP in Plasma (pmoles/ml) | 4 ± 1 | 7 ± 3 | 10 ± 4 | <0.05 | <0.0001 |
p < 0.05 | p < 0.001 | ||||
Lymphocyte basal cGMP (pmol/mg prot) | 0.169 ± 0.06 | 0.078 ± 0.06 | 0.047 ± 0.02 | ns | <0.0001 |
p < 0.001 | p < 0.01 | ||||
SNAP-induced cGMP increase (fold) | 11 ± 3 | 21 ± 9 | 22 ± 11 | ns | 0.0004 |
p < 0.01 | p < 0.01 | ||||
ANP (ng/ml) | 0.014 ± 0.003 | 0.015 ± 0.002 | 0.015 ± 0.002 | ns | ns |
IL-6 (pg/ml) | 1 ± 0.6 | 2.5 ± 1.5 | 4.7 ± 2.1 | <0.001 | <0.0001 |
p < 0.05 | p < 0.001 | ||||
IL-18 (pg/ml) | 174 ± 80 | 281 ± 138 | 388 ± 138 | <0.05 | <0.0001 |
p < 0.05 | p < 0.001 | ||||
Creatinine (mg/dl) | 0.74 ± 0.12 | 0.77 ± 0.19 | 0.86 ± 0.45 | ns | ns |
Total bilirubin (mg/dl) | 0.61 ± 0.16 | 1.42 ± 0.94 | 1.05 ± 0.83 | ns | 0.005 |
p = 0.003 | |||||
Albumin (g/dl) | 4.49 ± 0.14 | 3.90 ± 0.56 | 3.70 ± 0.59 | ns | <0.001 |
p = 0.001 | p < 0.001 | ||||
INR | 1.06 ± 0.05 | 1.22 ± 0.36 | 1.18 ± 0.17 | ns | 0.08 |
Ammonia (μM) | 72 ± 22 | 127 ± 40 | 131 ± 35 | ns | <0.001 |
p < 0.001 | p < 0.001 |